Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

SEC Declares Form S-4 Registration Statement Effective For Proposed Merger Of WaveDancer And Firefly Neuroscience; WaveDancer Will Hold A Special Meeting Of Its Stockholders To Approve The Proposed Merger On March 14, 2024, At 10:00 a.m. ET

Author: Benzinga Newsdesk | February 06, 2024 11:06am

WaveDancer, Inc. (NASDAQ:WAVD) ("WaveDancer") and Firefly Neuroscience, Inc. ("Firefly") announced today that the Registration Statement on Form S-4 (as amended or supplemented through the date hereof, the "Registration Statement") relating to the companies' proposed merger was declared effective by the Securities and Exchange Commission.  Accordingly, WaveDancer commenced the mailing of a definitive proxy statement to WaveDancer stockholders of record as of the close of business on February 1, 2024.

 

WaveDancer will hold a special meeting of its stockholders to approve the proposed merger on March 14, 2024, at 10:00 a.m. Eastern Time.

"We are very pleased that the Registration Statement has been declared effective and are now ready to move forward with our stockholder vote next month. We now expect to close earlier in the second quarter of 2024 than originally anticipated," said Jamie Benoit, Chairman and CEO of WaveDancer. "We hope that bringing Firefly and its FDA-cleared, Brain Network Analytics (BNA™) platform, developed with artificial intelligence (AI), to the Nasdaq will accelerate the company's ability to work with medical professionals to improve outcomes for people suffering from mental illnesses and cognitive disorders and we believe this transaction will translate into greater value for stockholders of both companies." 

Jon Olsen, CEO of Firefly added, "The parties have proceeded through this transaction with competence and professionalism, and we are excited to be one step closer to closing. We look forward to introducing the BNA™ Platform to clinics and pharmaceutical companies around the world and are ecstatic to be one step closer to being a publicly traded company." 

Posted In: WAVD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist